NeuroMetrix, Inc. 

(Public, NASDAQ:NURO)   Watch this stock   
Find more results for NURO
Nov 5, 2009
Q3 2009 Earnings Release
Nov 5, 2009
Q3 2009 Earnings Conference Call - Webcast
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin -26.62% -67.90%
Operating margin -27.57% -62.18%
EBITD margin - -63.81%
Return on average assets -26.84% -48.16%
Return on average equity -33.29% -60.75%
Employees 95 -

Address

62 Fourth Avenue
Waltham, MA 02451
United States - Map
+1-781-8909989 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

NeuroMetrix, Inc. discussed on blogs

Ranking 1100+ Micro Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

NeuroMetrix, Inc. discussions

  View all discussions »

Description

NeuroMetrix, Inc. is a science-based medical device company advancing patient care through the development and commercialization of products that aid physicians in the assessment, treatment, and repair of peripheral nerve and spinal cord injuries and disorders, and that provide regional anesthesia and pain control. The Company market systems for the performance of nerve conduction studies and needle electromyography procedures. They have two medical devices cleared by the United States Food and Drug Administration (FDA) that are used for the assessment of neuropathies. The first device is the ADVANCE NCS/EMG System, a platform for the performance of nerve conduction studies and needle electromyography procedures. This system is used by neurologists, physical medicine and rehabilitation (PM&R), physicians, neurosurgeons, orthopaedic, hand surgeons and pain medicine physicians. The second device is the NC-stat System, an automated device for the performance of nerve conduction studies.

Officers and directors

Shai N. Gozani M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, President, Secretary
Age: 45
Bio & Compensation - Reuters
Thomas T. Higgins
Chief Financial Officer, Senior Vice President
Age: 58
Bio & Compensation - Reuters
Walter Christensen
Senior Vice President - Global Sales
Bio & Compensation - Reuters
Guy Daniello
Senior Vice President - Information Technology
Age: 64
Bio & Compensation - Reuters
Michael Williams Ph.D.
Senior Vice President - Engineering
Age: 52
Bio & Compensation - Reuters
David E. Goodman M.D.
Director
Age: 53
Bio & Compensation - Reuters
W. Mark Lortz
Director
Age: 57
Bio & Compensation - Reuters
Charles R. LaMantia
Director
Age: 69
Bio & Compensation - Reuters
Allen J. Hinkle M.D.
Director
Age: 58
Bio & Compensation - Reuters
Timothy R. Surgenor
Director
Age: 49
Bio & Compensation - Reuters